Biotransformation of alprazolam by members of the human cytochrome P4503A subfamily

J. C. Gorski, D. R. Jones, M. A. Hamman, S. A. Wrighton, S. D. Hall

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

1. To aid in the prediction of drug interactions with alprazolam, the human CYP involved in the 1'- and 4-hydroxylation of alprazolam were characterized using human liver microsomes, expressed enzymes and selective chemical inhibitors. 2. The formation of 4-hydroxyalprazolam and 1'-hydroxyalprazolam at an alprazolam concentration of 62.5 μM were reduced by the prototypic CYP3A inhibitor, troleandomycin (50 μM), by 97 and 99% respectively. Only microsomes from B-lymphoblastoid cells expressing CYP3A4 were capable of catalysing the 1'- and 4-hydroxylation of alprazolam. 3. The formation rates of 1'-hydroxyalprazolam and 4-hydroxyalprazolam at an alprazolam concentration of 1 mM were significantly correlated (n = 19, r = 0.95, p < 0.01) indicating that the same enzyme(s) mediated these biotransformations. A significant (p < 0.01) correlation was observed between alprazolam 4- and 1'-hydroxylase activity and CYP3A-mediated midazolam 4-hydroxylase, midazolam 1'-hydroxylase, dextromethorphan N-demethylase and erythromycin N-demethylase activities. 4. In conclusion, in adult human liver the CYP3A subfamily members are the principal enzymes involved in the 1'- and 4-hydroxylation of alprazolam. Thus, clinically significant drug-drug interactions between alprazolam and other CYP3A substrates are to be expected.

Original languageEnglish
Pages (from-to)931-944
Number of pages14
JournalXenobiotica
Volume29
Issue number9
DOIs
StatePublished - 1999

Fingerprint

Alprazolam
Cytochromes
Biotransformation
Cytochrome P-450 CYP3A
Hydroxylation
Mixed Function Oxygenases
Drug interactions
Midazolam
Drug Interactions
Liver
Enzymes
N Demethylating Oxidoreductases
Troleandomycin
Dextromethorphan
Liver Microsomes
Microsomes
Cells

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Pharmacology
  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

Gorski, J. C., Jones, D. R., Hamman, M. A., Wrighton, S. A., & Hall, S. D. (1999). Biotransformation of alprazolam by members of the human cytochrome P4503A subfamily. Xenobiotica, 29(9), 931-944. https://doi.org/10.1080/004982599238173

Biotransformation of alprazolam by members of the human cytochrome P4503A subfamily. / Gorski, J. C.; Jones, D. R.; Hamman, M. A.; Wrighton, S. A.; Hall, S. D.

In: Xenobiotica, Vol. 29, No. 9, 1999, p. 931-944.

Research output: Contribution to journalArticle

Gorski, JC, Jones, DR, Hamman, MA, Wrighton, SA & Hall, SD 1999, 'Biotransformation of alprazolam by members of the human cytochrome P4503A subfamily', Xenobiotica, vol. 29, no. 9, pp. 931-944. https://doi.org/10.1080/004982599238173
Gorski, J. C. ; Jones, D. R. ; Hamman, M. A. ; Wrighton, S. A. ; Hall, S. D. / Biotransformation of alprazolam by members of the human cytochrome P4503A subfamily. In: Xenobiotica. 1999 ; Vol. 29, No. 9. pp. 931-944.
@article{4b8b94fc489d40949cbcadcc2ff8e900,
title = "Biotransformation of alprazolam by members of the human cytochrome P4503A subfamily",
abstract = "1. To aid in the prediction of drug interactions with alprazolam, the human CYP involved in the 1'- and 4-hydroxylation of alprazolam were characterized using human liver microsomes, expressed enzymes and selective chemical inhibitors. 2. The formation of 4-hydroxyalprazolam and 1'-hydroxyalprazolam at an alprazolam concentration of 62.5 μM were reduced by the prototypic CYP3A inhibitor, troleandomycin (50 μM), by 97 and 99{\%} respectively. Only microsomes from B-lymphoblastoid cells expressing CYP3A4 were capable of catalysing the 1'- and 4-hydroxylation of alprazolam. 3. The formation rates of 1'-hydroxyalprazolam and 4-hydroxyalprazolam at an alprazolam concentration of 1 mM were significantly correlated (n = 19, r = 0.95, p < 0.01) indicating that the same enzyme(s) mediated these biotransformations. A significant (p < 0.01) correlation was observed between alprazolam 4- and 1'-hydroxylase activity and CYP3A-mediated midazolam 4-hydroxylase, midazolam 1'-hydroxylase, dextromethorphan N-demethylase and erythromycin N-demethylase activities. 4. In conclusion, in adult human liver the CYP3A subfamily members are the principal enzymes involved in the 1'- and 4-hydroxylation of alprazolam. Thus, clinically significant drug-drug interactions between alprazolam and other CYP3A substrates are to be expected.",
author = "Gorski, {J. C.} and Jones, {D. R.} and Hamman, {M. A.} and Wrighton, {S. A.} and Hall, {S. D.}",
year = "1999",
doi = "10.1080/004982599238173",
language = "English",
volume = "29",
pages = "931--944",
journal = "Xenobiotica",
issn = "0049-8254",
publisher = "Informa Healthcare",
number = "9",

}

TY - JOUR

T1 - Biotransformation of alprazolam by members of the human cytochrome P4503A subfamily

AU - Gorski, J. C.

AU - Jones, D. R.

AU - Hamman, M. A.

AU - Wrighton, S. A.

AU - Hall, S. D.

PY - 1999

Y1 - 1999

N2 - 1. To aid in the prediction of drug interactions with alprazolam, the human CYP involved in the 1'- and 4-hydroxylation of alprazolam were characterized using human liver microsomes, expressed enzymes and selective chemical inhibitors. 2. The formation of 4-hydroxyalprazolam and 1'-hydroxyalprazolam at an alprazolam concentration of 62.5 μM were reduced by the prototypic CYP3A inhibitor, troleandomycin (50 μM), by 97 and 99% respectively. Only microsomes from B-lymphoblastoid cells expressing CYP3A4 were capable of catalysing the 1'- and 4-hydroxylation of alprazolam. 3. The formation rates of 1'-hydroxyalprazolam and 4-hydroxyalprazolam at an alprazolam concentration of 1 mM were significantly correlated (n = 19, r = 0.95, p < 0.01) indicating that the same enzyme(s) mediated these biotransformations. A significant (p < 0.01) correlation was observed between alprazolam 4- and 1'-hydroxylase activity and CYP3A-mediated midazolam 4-hydroxylase, midazolam 1'-hydroxylase, dextromethorphan N-demethylase and erythromycin N-demethylase activities. 4. In conclusion, in adult human liver the CYP3A subfamily members are the principal enzymes involved in the 1'- and 4-hydroxylation of alprazolam. Thus, clinically significant drug-drug interactions between alprazolam and other CYP3A substrates are to be expected.

AB - 1. To aid in the prediction of drug interactions with alprazolam, the human CYP involved in the 1'- and 4-hydroxylation of alprazolam were characterized using human liver microsomes, expressed enzymes and selective chemical inhibitors. 2. The formation of 4-hydroxyalprazolam and 1'-hydroxyalprazolam at an alprazolam concentration of 62.5 μM were reduced by the prototypic CYP3A inhibitor, troleandomycin (50 μM), by 97 and 99% respectively. Only microsomes from B-lymphoblastoid cells expressing CYP3A4 were capable of catalysing the 1'- and 4-hydroxylation of alprazolam. 3. The formation rates of 1'-hydroxyalprazolam and 4-hydroxyalprazolam at an alprazolam concentration of 1 mM were significantly correlated (n = 19, r = 0.95, p < 0.01) indicating that the same enzyme(s) mediated these biotransformations. A significant (p < 0.01) correlation was observed between alprazolam 4- and 1'-hydroxylase activity and CYP3A-mediated midazolam 4-hydroxylase, midazolam 1'-hydroxylase, dextromethorphan N-demethylase and erythromycin N-demethylase activities. 4. In conclusion, in adult human liver the CYP3A subfamily members are the principal enzymes involved in the 1'- and 4-hydroxylation of alprazolam. Thus, clinically significant drug-drug interactions between alprazolam and other CYP3A substrates are to be expected.

UR - http://www.scopus.com/inward/record.url?scp=0032829243&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032829243&partnerID=8YFLogxK

U2 - 10.1080/004982599238173

DO - 10.1080/004982599238173

M3 - Article

C2 - 10548453

AN - SCOPUS:0032829243

VL - 29

SP - 931

EP - 944

JO - Xenobiotica

JF - Xenobiotica

SN - 0049-8254

IS - 9

ER -